Shanghai No1 Pharmacy Co Ltd (600833) — Cash Flow-to-Debt Ratio
Shanghai No1 Pharmacy Co Ltd (600833) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CN¥-30.88 Million could theoretically repay 0% of its total liabilities (CN¥860.40 Million) in one year. See Shanghai No1 Pharmacy Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai No1 Pharmacy Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shanghai No1 Pharmacy Co Ltd across 28 annual periods. Also explore Shanghai No1 Pharmacy Co Ltd (600833) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai No1 Pharmacy Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Shanghai No1 Pharmacy Co Ltd. For market capitalisation and broader financial context, see Shanghai No1 Pharmacy Co Ltd (600833) total market value.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥88.88 Million | CN¥850.46 Million | ▲ +78.1% |
| 2024 | 0.06x | CN¥49.03 Million | CN¥835.66 Million | ▼ -14.3% |
| 2023 | 0.07x | CN¥58.49 Million | CN¥854.72 Million | ▼ -44.1% |
| 2022 | 0.12x | CN¥132.31 Million | CN¥1.08 Billion | ▲ +86.4% |
| 2021 | 0.07x | CN¥36.56 Million | CN¥556.54 Million | ▼ -49.6% |
| 2020 | 0.13x | CN¥84.24 Million | CN¥646.94 Million | ▼ -39.7% |
| 2019 | 0.22x | CN¥104.60 Million | CN¥484.21 Million | ▲ +106.9% |
| 2018 | 0.10x | CN¥42.79 Million | CN¥409.90 Million | ▼ -63.3% |
| 2017 | 0.28x | CN¥120.07 Million | CN¥421.90 Million | ▲ +251.6% |
| 2016 | 0.08x | CN¥36.37 Million | CN¥449.29 Million | ▼ -25.9% |
| 2015 | 0.11x | CN¥48.82 Million | CN¥447.04 Million | ▲ +144.6% |
| 2014 | 0.04x | CN¥19.20 Million | CN¥430.01 Million | ▲ +160.2% |
| 2013 | 0.02x | CN¥6.52 Million | CN¥380.03 Million | ▼ -88.0% |
| 2012 | 0.14x | CN¥56.25 Million | CN¥392.43 Million | ▲ +112.0% |
| 2011 | 0.07x | CN¥24.67 Million | CN¥364.80 Million | ▼ -40.3% |
| 2010 | 0.11x | CN¥39.92 Million | CN¥352.30 Million | ▲ +33.7% |
| 2009 | 0.08x | CN¥27.06 Million | CN¥319.32 Million | ▲ +12.5% |
| 2008 | 0.08x | CN¥20.71 Million | CN¥274.95 Million | ▼ -44.8% |
| 2007 | 0.14x | CN¥41.35 Million | CN¥303.03 Million | ▼ -61.3% |
| 2006 | 0.35x | CN¥83.00 Million | CN¥235.38 Million | ▲ +175.3% |
| 2005 | 0.13x | CN¥14.21 Million | CN¥110.98 Million | ▲ +891.3% |
| 2004 | 0.01x | CN¥2.92 Million | CN¥226.40 Million | ▼ -85.5% |
| 2003 | 0.09x | CN¥26.30 Million | CN¥295.59 Million | ▲ +7.1% |
| 2002 | 0.08x | CN¥25.09 Million | CN¥302.08 Million | ▼ -53.4% |
| 2001 | 0.18x | CN¥56.49 Million | CN¥317.24 Million | ▲ +7696.3% |
| 2000 | 0.00x | CN¥2.01 Million | CN¥879.40 Million | ▲ +190.3% |
| 1999 | 0.00x | CN¥-2.59 Million | CN¥1.02 Billion | ▲ +98.3% |
| 1998 | -0.15x | CN¥-132.68 Million | CN¥886.85 Million | — |